Literature DB >> 17002933

Utility of plasma free metanephrines in diagnosis of factitious pheochromocytoma.

Aaron R Chidakel1, Karel Pacak, Graeme Eisenhofer, Jennifer E Lawrence, Alejandro R Ayala.   

Abstract

OBJECTIVE: To report a case of epinephrine-induced factitious pheochromocytoma in a young woman with a past medical history of Conn's syndrome.
METHODS: We present a case report with clinical and laboratory details, review related reports in the literature, and demonstrate the usefulness of plasma free metanephrine levels in facilitating the diagnosis of factitious pheochromocytoma.
RESULTS: A 34-year-old woman was admitted to our hospital for confirmation and localization of an occult pheochromocytoma. After thorough investigation, we discovered that the patient was surreptitiously injecting epinephrine in order to induce symptoms and signs consistent with a pheochromocytoma. Analysis of the patient's biochemical profile during and between her catecholaminergic crises revealed plasma epinephrine and free metanephrine levels that would be highly unusual for a patient with a pheochromocytoma.
CONCLUSION: This case illustrates the utility of implementing the ratio of plasma epinephrine to free metanephrine levels in distinguishing factitious from organic pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002933     DOI: 10.4158/EP.12.5.568

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  3 in total

1.  Pheochromocytoma or Münchausen syndrome: the masquerade is up.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2010-04-27       Impact factor: 4.435

2.  Tachyarrythmias with elevated cardiac enzymes in Münchausen syndrome.

Authors:  Lucy Norcliffe-Kaufmann; Alejandra Gonzalez-Duarte; Jose Martinez; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2010-04-28       Impact factor: 4.435

Review 3.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.